We are live on ! Find out more
AHCO icon

AdaptHealth

35 hedge funds and large institutions have $390M invested in AdaptHealth in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

57% more capital invested

Capital invested by funds: $248M → $390M (+$142M)

52% more funds holding

Funds holding: 2335 (+12)

1.01% more ownership

Funds ownership: 56.07%57.08% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
35
Holders Change
+12
Holders Change %
+52.17%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
19
Increased
9
Reduced
3
Closed
7
Calls
$4M
Puts
Net Calls
+$4M
Net Calls Change
+$1.25M

AHCO Hedge Fund Activity: Q1 2020 in Review

35 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q1 2020, worth a combined $390M — up 57% from $248M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AHCO positions and 7 closed out — a net gain of 12 holders — while 9 added to existing stakes and 3 trimmed.

The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $8.12M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $3.81M sold.

  • 35 institutional investors held AdaptHealth (AHCO) as of Q1 2020, up from 23 in Q4 2019.
  • Funds reported $390M of AdaptHealth stock for Q1 2020, up 57% quarter-over-quarter.
  • 19 funds opened new AdaptHealth positions in Q1 2020 and 7 closed out, a net change of +12 holders.
  • The largest AdaptHealth buyer in Q1 2020 was Bank of New York Mellon, an estimated $8.12M added.
  • The largest AdaptHealth seller in Q1 2020 was Alyeska Investment Group, an estimated $3.81M sold.

Based on aggregated 13F filings for Q1 2020.